We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.

Already a subscriber and want to update your preferences? Click here.

BACK TO NEWS

MEDIA MENTIONS

FEB 15 2021

Azurity Pharmaceuticals Announces Three New Neurology Products

Rajiv Khanna, shareholder and Audrey Distler, associate in the firm’s Corporate section, represented Azurity Pharmaceuticals in a recent transaction in which the company purchased a three-part neurology product portfolio. More details on the transaction can be found here.